These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 37141638)
1. Neuroglobin inhibits pancreatic cancer proliferation and metastasis by targeting the GNAI1/EGFR/AKT/ERK signaling axis. Wu F; He J; Deng Q; Chen J; Peng M; Xiao J; Zeng Y; Yi L; Li Z; Tian R; Jiang Z Biochem Biophys Res Commun; 2023 Jul; 664():108-116. PubMed ID: 37141638 [TBL] [Abstract][Full Text] [Related]
2. HHLA2 deficiency inhibits pancreatic cancer progression and THP-1 macrophage M2 polarization via EGFR/MAPK/ERK and mTOR/AKT pathway. Zhou S; Wang Z; Zhao D; Fu Y; Zhang S; Wang Z; Zou X World J Surg Oncol; 2024 May; 22(1):133. PubMed ID: 38762741 [TBL] [Abstract][Full Text] [Related]
3. Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk. Zhang J; Lan SJ; Liu QR; Liu JM; Chen XQ Mol Pharmacol; 2013 May; 83(5):1109-19. PubMed ID: 23478801 [TBL] [Abstract][Full Text] [Related]
4. AREG mediates the epithelial‑mesenchymal transition in pancreatic cancer cells via the EGFR/ERK/NF‑κB signalling pathway. Wang L; Wang L; Zhang H; Lu J; Zhang Z; Wu H; Liang Z Oncol Rep; 2020 May; 43(5):1558-1568. PubMed ID: 32323797 [TBL] [Abstract][Full Text] [Related]
5. Neuroglobin promotes the proliferation and suppresses the apoptosis of glioma cells by activating the PI3K/AKT pathway. Zhang B; Liu Y; Li Y; Zhe X; Zhang S; Zhang L Mol Med Rep; 2018 Feb; 17(2):2757-2763. PubMed ID: 29207186 [TBL] [Abstract][Full Text] [Related]
6. Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways. Li W; Wang Z; Xiao X; Han L; Wu Z; Ma Q; Cao L Oncol Rep; 2019 Jan; 41(1):650-658. PubMed ID: 30542713 [TBL] [Abstract][Full Text] [Related]
7. Loss of Neuroglobin Expression Alters Cdkn1a/Cdk6-Expression Resulting in Increased Proliferation of Neural Stem Cells. Luyckx E; Van Leuven W; Andre D; Quarta A; Reekmans K; Fransen E; Moens L; Hankeln T; Ponsaerts P; Dewilde S Stem Cells Dev; 2018 Mar; 27(6):378-390. PubMed ID: 29357734 [TBL] [Abstract][Full Text] [Related]
8. Neuroglobin plays as tumor suppressor by disrupting the stability of GPR35 in colorectal cancer. Xiang Q; Zhou D; Xiang X; Le X; Deng C; Sun R; Li C; Pang H; He J; Zheng Z; Tang J; Peng W; Peng X; He X; Wu F; Qiu J; Xu Y; Xiang T Clin Epigenetics; 2023 Apr; 15(1):57. PubMed ID: 37005662 [TBL] [Abstract][Full Text] [Related]
9. Radiosensitization of epidermal growth factor receptor/HER2-positive pancreatic cancer is mediated by inhibition of Akt independent of ras mutational status. Kimple RJ; Vaseva AV; Cox AD; Baerman KM; Calvo BF; Tepper JE; Shields JM; Sartor CI Clin Cancer Res; 2010 Feb; 16(3):912-23. PubMed ID: 20103665 [TBL] [Abstract][Full Text] [Related]
10. Saikosaponin-A Exhibits Antipancreatic Cancer Activity by Targeting the EGFR/PI3K/Akt Pathway. Shi C; Sun L; Fang R; Zheng S; Yu M; Li Q Curr Pharm Biotechnol; 2023; 24(4):579-588. PubMed ID: 35692139 [TBL] [Abstract][Full Text] [Related]
11. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway. Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421 [TBL] [Abstract][Full Text] [Related]
12. Dissecting the 17β-estradiol pathways necessary for neuroglobin anti-apoptotic activity in breast cancer. Fiocchetti M; Cipolletti M; Ascenzi P; Marino M J Cell Physiol; 2018 Jul; 233(7):5087-5103. PubMed ID: 29219195 [TBL] [Abstract][Full Text] [Related]
13. Neuroglobin functions as a prognostic marker and promotes the tumor growth of glioma via suppressing apoptosis. Zhang B; Chang M; Wang J; Liu Y Biomed Pharmacother; 2017 Apr; 88():173-180. PubMed ID: 28103511 [TBL] [Abstract][Full Text] [Related]
14. The effect of ibrutinib on radiosensitivity in pancreatic cancer cells by targeting EGFR/AKT/mTOR signaling pathway. Tan B; Huang Y; Zhang B; Lin N Biomed Pharmacother; 2020 Aug; 128():110133. PubMed ID: 32447207 [TBL] [Abstract][Full Text] [Related]
15. Kaempferol potentiates the sensitivity of pancreatic cancer cells to erlotinib via inhibition of the PI3K/AKT signaling pathway and epidermal growth factor receptor. Zhang Z; Guo Y; Chen M; Chen F; Liu B; Shen C Inflammopharmacology; 2021 Oct; 29(5):1587-1601. PubMed ID: 34322786 [TBL] [Abstract][Full Text] [Related]
16. Potentiation of paclitaxel effect by resveratrol in human breast cancer cells by counteracting the 17β-estradiol/estrogen receptor α/neuroglobin pathway. Cipolletti M; Montalesi E; Nuzzo MT; Fiocchetti M; Ascenzi P; Marino M J Cell Physiol; 2019 Apr; 234(4):3147-3157. PubMed ID: 30421506 [TBL] [Abstract][Full Text] [Related]
17. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer. Baumgartner U; Berger F; Hashemi Gheinani A; Burgener SS; Monastyrskaya K; Vassella E Mol Cancer; 2018 Feb; 17(1):44. PubMed ID: 29455644 [TBL] [Abstract][Full Text] [Related]
18. CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway. Li L; Hu Y; Chen D; Zhu J; Bao W; Xu X; Chen H; Chen W; Feng R Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34791506 [TBL] [Abstract][Full Text] [Related]
19. DTX3L Accelerates Pancreatic cancer Progression via FAK/PI3K/AKT Axis. Chen L; Niu W; Zang H; Qiu Y Biochem Genet; 2024 Apr; 62(2):814-830. PubMed ID: 37460862 [TBL] [Abstract][Full Text] [Related]
20. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR. Li L; Zhang S; Li H; Chou H BMC Cancer; 2019 Oct; 19(1):963. PubMed ID: 31619201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]